Microbot Medical Inc. — Board/Management Information 2016

May 3, 2016

8-K 1 htm_53436.htm LIVE FILING CoverPageHeader start html PUBLIC "-//W3C//DTD HTML 3.2//EN" StemCells, Inc. (Form: 8-K)

CoverPageHeader end CoverPageTitle START

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 2, 2016

CoverPageTitle END CoverPageRegistrant START

StemCells, Inc. ______ (Exact name of registrant as specified in its charter)

Delaware	000-19871	94-3078125
___ (State or other jurisdiction	_______ (Commission	__ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
7707 Gateway Blvd, Suite 140, Newark, California		94560
_________ (Address of principal executive offices)		_____ (Zip Code)

Registrant’s telephone number, including area code: 510.456.4000

Not Applicable __________ Former name or former address, if changed since last report

CoverPageRegistrant END

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

PageBreak START

Top of the Form

PageBreak END Item START

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective May 2, 2016, the Board of Directors of StemCells, Inc. (the "Company") unanimously approved an amendment to the Company's Amended and Restated By-laws to remove certain provisions concerning intra-partes disputes adopted by the Company in 2015. The full text of the Company's Amended and Restated By-laws, as revised, is attached hereto as Exhibit 3(ii).

Item END

PageBreak START

Top of the Form

PageBreak END SignatureHeader START

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SignatureHeader END Signature START

Kenneth Stratton
Name: Kenneth Stratton
Title: General Counsel

Signature END PageBreak START

Top of the Form

PageBreak END

Exhibit Index

Exhibit No.	Description
3.(ii)	Amended and Restated By-laws of StemCells, Inc.

HTMLFooter START HTMLFooter END